Bharat Immunological Share Price

Overview 

Bharat Immunological & Biologicals Corporation Limited, with its corporate operations in Bulandshahr, functions as a biotechnology company engaged in the manufacture and sale of pharmaceutical products. The company was incorporated on March 10, 1989 and is headquartered in Bulandshahr, Uttar Pradesh, India. Bharat Immunological & Biologicals Corporation was established by the Department of Biotechnology, Ministry of Science & Technology, Government of India as a Central Public Sector Unit and incorporated under the Companies Act, 1956. The company primarily manufactures Oral Polio Vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). The group principally operates in India and generates the majority of its revenue from sales of Oral Polio Vaccines. 

Bharat Immunological & Biologicals Corporation share price on BSE signifies how market participants react to the company’s operational performance and the overall developments in the biotechnology and pharmaceutical sector. The company’s financial health depends on demand for vaccines and pharmaceutical products from government healthcare programs, manufacturing efficiency, raw material costs, and the performance of its production operations. Bharat Immunological & Biologicals Corporation stock price is influenced by various factors such as earnings, fluctuations in raw material costs, regulatory changes in pharmaceutical manufacturing, and government healthcare policies. In the longer run, strategies such as expanding product portfolio, strengthening manufacturing capabilities, and developing new biological products affect the stock market sentiments. All these factors need to be monitored closely to have an idea about the company’s stock price movements. 

Bharat Immunological & Biologicals Corporation live share price provides real time information about the last price traded, bid and ask prices, and volume traded. These indicators represent market activity and liquidity, reflecting investor response to corporate announcements, economic conditions, and sector news. Constant monitoring of the Bharat Immunological & Biologicals Corporation live price helps in observing short term price volatility and shows how a stock moves relative to the broader biotechnology and pharmaceutical indices. Furthermore, monitoring Bharat Immunological & Biologicals Corporation stock price movements helps investors understand real time market sentiment, price fluctuations, and trading behaviour. It allows them to evaluate short term performance, and respond to news, quarterly results, or sector trends that may influence the company’s valuation and overall investment outlook. 

Bharat Immunological & Biologicals Corporation Limited Company Fundamentals 

A. Company Background

Bharat Immunological & Biologicals Corporation Limited was incorporated on March 10, 1989 and is headquartered in Bulandshahr, Uttar Pradesh, India. The company was established by the Department of Biotechnology, Ministry of Science & Technology, Government of India as a Central Public Sector Unit and incorporated under the Companies Act, 1956. The company is a biotechnology company engaged in the manufacture and sale of pharmaceutical products. The company primarily manufactures Oral Polio Vaccines. In addition, the company also manufactures zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF). The group principally operates in India and generates the majority of its revenue from sales of Oral Polio Vaccines. Corporate functions are managed from its administrative offices in Bulandshahr. 

B. Company Product Lines

• Oral Polio Vaccines 

• Oral polio vaccines (OPV) 

• Pharmaceutical Products 

• Zinc tablets 

• Diarrhea management kits 

• Nutritional Products 

• Ready to Use Therapeutic Food (RUTF) 

• Other Products 

• BIB sweet tablets 

C. Company Revenue Model

• Domestic Sales 

• Revenue generated through vaccine and pharmaceutical product sales in India 

• Government Contracts 

• Supply agreements with government healthcare programs 

• Product Revenue 

• Income from sale of vaccines, tablets, and therapeutic food 

D. Geographic Presence

• Global Headquarters 

• Primary administrative and management functions based in Bulandshahr, Uttar Pradesh, India 

• Operations 

• India 

E. Key Milestones

• 1989 – Incorporation: The company was incorporated on March 10, 1989 

• 2021 – Turnover: The company had a turnover of Rs. 8,533.36 Lakhs during the year 2020-21 

F. Industry Perspective

The biotechnology and pharmaceutical industry is closely linked to demand from healthcare systems and government immunization programs. Demand trends are influenced by healthcare spending, disease prevalence, regulatory approvals, and government health policies. The industry is also affected by fluctuations in raw material prices, along with regulatory changes and currency exchange rates. Companies in the sector must manage manufacturing efficiency, quality standards, and regulatory compliance while maintaining operational flexibility. These factors collectively influence financial performance and investor perception of firms like Bharat Immunological & Biologicals Corporation. 

Bharat Immunological & Biologicals Corporation Limited Stock Market Presence: Listings & Index Representation 

Bharat Immunological & Biologicals Corporation Limited is listed on the Bombay Stock Exchange with the scrip code 524663. Bharat Immunological & Biologicals Corporation share price is actively traded on the exchange. The company’s market presence is within the micro-cap segment of the market. Due to its size and sector focus, Bharat Immunological & Biologicals Corporation share price is generally tracked by investors interested in the biotechnology and pharmaceutical sector. 

Bharat Immunological & Biologicals Corporation Limited is part of several broad-based and sector-specific stock market indices, reflecting its position as a biotechnology company in India. It finds representation in indices based on its market standing. Bharat Immunological & Biologicals Corporation stock price is monitored by investors tracking the pharmaceutical and healthcare sectors. The company’s presence in these indices helps investors track the stock relative to other pharmaceutical companies. Bharat Immunological & Biologicals Corporation stock price is observed by market participants as an indicator of the performance of the biotechnology sector in India. 

Bharat Immunological & Biologicals Corporation Limited Stock Performance and Share Price History 

Bharat Immunological & Biologicals Corporation share price on the BSE reflects its position as a biotechnology company in India. Its performance is qualitatively driven by factors such as vaccine production volumes, management of raw material costs, growth in government contracts, and the ability to maintain quality standards. Investors compare Bharat Immunological & Biologicals Corporation share price movement with other pharmaceutical companies to assess relative strength. 

These underlying factors become visible through real market movements across different time periods. Similar trends appear during earnings driven price changes. Broader sector strength has also supported Bharat Immunological & Biologicals Corporation share price at certain times. Beyond operational and sector influences, corporate actions such as the company’s expansion into new product categories can significantly affect share price movements by shaping future growth expectations. This shows how strategic initiatives may trigger short term swings, even within a regulatory environment influenced by government health policies and vaccine demand cycles. 

While short term movements respond to events and announcements, longer term valuation trends are better captured by Bharat Immunological & Biologicals Corporation share price annual high and low levels, offering context beyond daily or weekly changes. A notable peak indicates stronger vaccine demand and stable margins, whereas a significant low aligns with market corrections or sector volatility. These extremes reflect the impact of economic conditions, raw material price fluctuations, and earnings visibility, providing a framework for understanding historical performance. 

Bharat Immunological & Biologicals Corporation share price behaviour mirrors the trading patterns of a biotechnology company within India’s pharmaceutical ecosystem. The company’s focus on oral polio vaccines and pharmaceutical products has shaped its price history. Over the past several years, Bharat Immunological & Biologicals Corporation share price has experienced periods of sharp gains followed by phases of consolidation. Bharat Immunological & Biologicals Corporation share price has shown certain volatility patterns reflecting the cyclical nature of its manufacturing operations. 

The company’s performance has closely tracked government health programs and vaccine demand cycles. Positive momentum appeared during periods of strong government procurement and favourable healthcare policies. However, periods of weak vaccine demand and intensified competition have led to consolidation in Bharat Immunological & Biologicals Corporation share price. Bharat Immunological & Biologicals Corporation share price faced selling pressure when raw material costs showed significant increases, reflecting structural challenges in managing input cost volatility in the pharmaceutical sector. 

Despite macroeconomic disruptions, Bharat Immunological & Biologicals Corporation share price showed resilience during recovery phases. While the broader pharmaceutical sector faced challenges, the company’s established government relationships helped Bharat Immunological & Biologicals Corporation share price recover from lows. The company maintains its manufacturing capabilities and continues to invest in product development. 

Bharat Immunological & Biologicals Corporation share price has declined for several recurring reasons. A drop in vaccine demand or lower government procurement directly impacts revenue visibility and leads to selling pressure. Changes in government policy on healthcare or vaccine procurement can also cause Bharat Immunological & Biologicals Corporation share price to fall. Moreover, increases in operational costs such as raw material prices without matching productivity gains squeeze margins, making Bharat Immunological & Biologicals Corporation share price less attractive. Periods of economic slowdown that affect government healthcare spending raise concerns about demand pipelines, leading to price declines. Bharat Immunological & Biologicals Corporation share price is sensitive to currency exchange rate movements. Broader market sell offs in pharmaceutical stocks also pull the price down, regardless of the company’s individual performance. 

Bharat Immunological & Biologicals Corporation stock price has seen downward pressure when the company reported fluctuations in profit margins. Bharat Immunological & Biologicals Corporation stock price movements often mirror broader pharmaceutical sector trends. Bharat Immunological & Biologicals Corporation stock price can be impacted by changes in vaccine demand and raw material costs. Bharat Immunological & Biologicals Corporation stock price has historically shown sensitivity to government health policies. Bharat Immunological & Biologicals Corporation stock price may also be affected by the company’s ability to maintain its competitive edge in vaccine manufacturing. Bharat Immunological & Biologicals Corporation stock price performance is closely watched by investors tracking the pharmaceutical segment. Bharat Immunological & Biologicals Corporation stock price has moved within a range reflecting the broader market correction in pharmaceutical stocks. 

Bharat Immunological & Biologicals Corporation Limited Investor Relevance and Role in Portfolio 

Bharat Immunological & Biologicals Corporation Limited is a holding in biotechnology and pharmaceutical sector portfolios, offering exposure to vaccine manufacturing, pharmaceutical products, and therapeutic nutrition. Its presence in the biotechnology space underscores its importance in India’s healthcare sector. The company’s position as a Central Public Sector Unit engaged in vaccine manufacturing makes it a consideration for long term allocations. 

Bharat Immunological & Biologicals Corporation share price is influenced by the company’s ownership structure. The company’s equity is held by the Government of India as a Central Public Sector Unit, institutional investors, and retail investors, reflecting its standing in India’s pharmaceutical sector. This investor base, with stable government participation, underscores the company’s role as a holding in both domestic and international portfolios concentrating on healthcare services. 

Beyond fundamentals and ownership, Bharat Immunological & Biologicals Corporation share price is actively monitored in cash market segments, where trading volumes and delivery patterns reflect expectations on vaccine demand, government procurement, and regulatory policy actions. Bharat Immunological & Biologicals Corporation stock price is available for trading on the major Indian exchange, allowing investors to take positions based on their outlook for the pharmaceutical sector. Market participants watch these trading indicators to gauge sentiment around quarterly results and policy announcements. 

Technical indicators provide additional insight into short term momentum shifts in Bharat Immunological & Biologicals Corporation share price. While these indicators are primarily used for near term trading decisions, they also help investors and portfolio managers understand broader market sentiment and anticipate potential volatility, especially around key events or announcements. In the short term and weekly timeframe, the stock has exhibited price movements that correlate with broader pharmaceutical sector trends. The company’s financial position reflects its operational performance in the manufacturing segment. 

Overall, Bharat Immunological & Biologicals Corporation demonstrates a certain volatility profile compared to the broader market, with the stock generally considered to have exposure to sector specific factors such as vaccine demand, raw material costs, and currency fluctuations. Bharat Immunological & Biologicals Corporation share price is influenced by these factors. Bharat Immunological & Biologicals Corporation stock price reflects the company’s position in the biotechnology space. 

Bharat Immunological & Biologicals Corporation Limited Sectoral Relevance and Peer Positioning 

Bharat Immunological & Biologicals Corporation Limited sector relevance stems from its presence in the biotechnology and pharmaceutical industry, its position as a Central Public Sector Unit established by the Department of Biotechnology, its portfolio covering Oral Polio Vaccines, zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food (RUTF), its operation primarily in India with majority revenue from Oral Polio Vaccines, its incorporation in 1989, and its status as a biotechnology company with a focus on vaccines and healthcare products. Peer comparisons with companies in the pharmaceutical and biotechnology sector focus on manufacturing capacity, product quality, and operational scale rather than short term stock moves. These benchmarks help investors assess operational scale, efficiency, and regulatory adherence. Institutional tracking of vaccine demand, government health policies, and regulatory changes further highlights Bharat Immunological & Biologicals Corporation positioning within the broader pharmaceutical market. 

Bharat Immunological & Biologicals Corporation market cap highlights its position as a player within the biotechnology sector. The company’s market capitalization has moved in line with investor perceptions of the company’s growth potential following its expansion into new product categories. From earlier periods through more recent times, the market cap showed trends as the company maintained its manufacturing operations. This pattern reflects investor confidence during favourable vaccine demand cycles, followed by consolidation during challenging periods impacted by macroeconomic headwinds. This movement mirrors the correction in Bharat Immunological & Biologicals Corporation share price from its highs to recent levels. 

Bharat Immunological & Biologicals Corporation earnings trajectory demonstrates the impact of its operational execution in a competitive industry. In recent fiscal years, total income showed trends supported by the core vaccine and pharmaceutical businesses. The company’s revenue from operations showed movements supported by government procurement. Profit after tax demonstrated operational performance. However, the company has faced headwinds from fluctuating raw material prices, intensified competition, and regulatory changes. However, the company has continued to maintain its manufacturing operations and supply products to government healthcare programs. These developments illustrate the evolving nature of the pharmaceutical industry and the company’s position within this sector. 

Bharat Immunological & Biologicals Corporation EPS provides insight into its operational performance and income generation from vaccine manufacturing activities. The company reported earnings that varied based on vaccine cycles and government procurement patterns. The earnings per share has shown movements over time as the company navigated changing market conditions. The company has a face value per share. More recent quarterly performance suggests that EPS has shown movements as the company continues its manufacturing operations. 

Bharat Immunological & Biologicals Corporation P/E ratio reflects how investors perceive the company’s earnings relative to its revenue streams from vaccines and pharmaceuticals. The current valuation compared to industry averages indicates how the market assesses the company’s earnings potential. The company’s profit after tax has shown variations across recent fiscal periods based on operational performance. Overall, these changes highlight how market sentiment evolved alongside the company’s operational performance in a dynamic industry undergoing structural transformation. Bharat Immunological & Biologicals Corporation share price continues to be watched by market participants. 

Summary 

Bharat Immunological & Biologicals Corporation Limited, headquartered in Bulandshahr, operates as a biotechnology company and Central Public Sector Unit manufacturing Oral Polio Vaccines, zinc tablets, diarrhea management kits, and Ready to Use Therapeutic Food. The company, incorporated in 1989, serves clients across domestic markets. Bharat Immunological & Biologicals Corporation share price reflects market perceptions of the company’s vaccine manufacturing capabilities and product quality. Bharat Immunological & Biologicals Corporation stock price movements are influenced by vaccine demand, government procurement, and healthcare policies, making it a consideration for investors tracking the biotechnology and pharmaceutical sector.